Stockscreener 앱 받기
4.00
4.44%
0.17
시간 외 거래:
4.00
Elutia Inc 주식(ELUT)의 최신 뉴스
Elutia Inc. (NASDAQ:ELUT) Sees Large Decrease in Short Interest - Defense World
Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices - StockTitan
Short Interest in Elutia Inc. (NASDAQ:ELUT) Decreases By 10.9% - MarketBeat
Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators - HMP Global Learning Network
AIGH Capital Management LLC Increases Position in Elutia Inc. (NASDAQ:ELUT) - MarketBeat
Cantor Fitzgerald Reiterates “Overweight” Rating for Elutia (NASDAQ:ELUT) - Defense World
Elutia Celebrates First Year - ForexTV.com
Elutia Celebrates First Year - EIN News
Elutia (NASDAQ:ELUT) Receives Overweight Rating from Cantor Fitzgerald - MarketBeat
Elutia Celebrates First Year - StockTitan
Elutia Announces First Patient Implant of EluPro™, the - GlobeNewswire
Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators - StockTitan
Elutia to Participate in Upcoming Investor Conferences - ForexTV.com
Elutia to Participate in Upcoming Investor Conferences - StockTitan
Contaminated donor tissue gave Georgia patient tuberculosis, lawsuit says - The Atlanta Journal Constitution
Ryan Marques Joins Elutia As VP Of Operations - MPO-mag
Short Interest in Elutia Inc. (NASDAQ:ELUT) Expands By 468.3% - Defense World
Elutia Inc. (NASDAQ:ELUT) Short Interest Update - MarketBeat
Spine Implant Caused Patient's TB, Suit Says - Law360
ELUT (Elutia) Financial Strength : 2 (As of Jun. 2024) - GuruFocus.com
ELUT (Elutia) Cash from Discontinued Operating Activities : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com
Elutia Inc. (ELUT) Q2 2024 Earnings Call Transcript - Seeking Alpha
Elutia (NASDAQ:ELUT) Price Target Cut to $10.00 - MarketBeat
Elutia Wins FDA Clearance Of Its Antibiotic-Eluting BioEnvelope - MPO-mag
Elutia Announces Second Quarter 2024 Results - StockTitan
Elutia (ELUT) Set to Announce Earnings on Wednesday - Defense World
Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds - StockTitan
Are Medical Stocks Lagging DiaMedica Therapeutics (DMAC) This Year? - Yahoo Finance
Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations - citybiz
Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations - StockTitan
Elutia (ELUT) Set to Announce Earnings on Wednesday - MarketBeat
BioCardia Submits for FDA Approval of Morph DNA Steerable Introducer Product Family - Diagnostic and Interventional Cardiology
ELUTElutia Inc. Latest Stock News & Market Updates - StockTitan
Elutia Inc. (NASDAQ:ELUT) Sees Significant Drop in Short Interest - MarketBeat
Elutia Inc. (NASDAQ:ELUT) Sees Large Drop in Short Interest - Defense World
Beat the Market Like Zacks: Karooooo, UnitedHealth, Amgen in Focus - MSN
Beat the Market Like Zacks: Karooooo, UnitedHealth, Amgen in Focus - Yahoo Finance
Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now - GlobeNewswire
Elutia Inc. (NASDAQ:ELUT) Short Interest Up 1,408.3% in June - Defense World
7 Growth Stocks to Buy for Under $5 for Massive Gains - InvestorPlace
Elutia Inc. (NASDAQ:ELUT) Sees Significant Growth in Short Interest - MarketBeat
Elutia to Present at the Emerging Growth Conference on Thursday, July 18 - StockTitan
Elutia to Present at the Emerging Growth Conference on Thursday, July 18 - ForexTV.com
Reviewing Elutia (NASDAQ:ELUT) & Neurocrine Biosciences (NASDAQ:NBIX) - Defense World
Elutia Inc.'s (NASDAQ:ELUT) Share Price Boosted 28% But Its Business Prospects Need A Lift Too - Simply Wall St
Zacks.com featured highlights BRC, Costamare and Elutia - Yahoo Finance
3 Best Breakout Stocks Worth a Buy for Attractive Returns - Zacks Investment Research
Cantor Fitzgerald Analysts Increase Earnings Estimates for Elutia Inc. (NASDAQ:ELUT) - MarketBeat
Head-To-Head Contrast: Elutia (NASDAQ:ELUT) & Fennec Pharmaceuticals (NASDAQ:FENC) - Defense World
Elutia Inc. to Post FY2024 Earnings of ($1.37) Per Share, Cantor Fitzgerald Forecasts (NASDAQ:ELUT) - Defense World
0.08%
1.04%
자본화:
|
볼륨(24시간):